These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36713812)
1. DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1. Mitchell AV; Wu J; Meng F; Dong L; Block CJ; Song WM; Zhang B; Li J; Wu G Cancer Res Commun; 2022 Nov; 2(11):1388-1403. PubMed ID: 36713812 [TBL] [Abstract][Full Text] [Related]
2. SNAI1-mediated transcriptional regulation of epithelial-to-mesenchymal transition genes in breast cancer stem cells. Singh D; Deshmukh RK; Das A Cell Signal; 2021 Nov; 87():110151. PubMed ID: 34537302 [TBL] [Abstract][Full Text] [Related]
3. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer. Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011 [TBL] [Abstract][Full Text] [Related]
4. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253 [TBL] [Abstract][Full Text] [Related]
5. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail. Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028 [TBL] [Abstract][Full Text] [Related]
6. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer. Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547 [TBL] [Abstract][Full Text] [Related]
7. DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Lin CC; Yang WH; Lin YT; Tang X; Chen PH; Ding CC; Qu DC; Alvarez JV; Chi JT Oncogene; 2021 Mar; 40(11):2018-2034. PubMed ID: 33603168 [TBL] [Abstract][Full Text] [Related]
8. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653 [TBL] [Abstract][Full Text] [Related]
9. AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation. Wang M; Zhao F; Li S; Chang AK; Jia Z; Chen Y; Xu F; Pan H; Wu H PLoS One; 2013; 8(6):e65556. PubMed ID: 23762395 [TBL] [Abstract][Full Text] [Related]
10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
11. FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Qiao Y; Jiang X; Lee ST; Karuturi RK; Hooi SC; Yu Q Cancer Res; 2011 Apr; 71(8):3076-86. PubMed ID: 21346143 [TBL] [Abstract][Full Text] [Related]
12. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia. Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389 [TBL] [Abstract][Full Text] [Related]
13. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer. Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865 [TBL] [Abstract][Full Text] [Related]
14. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. Mitchell AV; Wu L; James Block C; Zhang M; Hackett J; Craig DB; Chen W; Zhao Y; Zhang B; Dang Y; Zhang X; Zhang S; Wang C; Gibson H; Pile LA; Kidder B; Matherly L; Yang Z; Dou Y; Wu G Nat Commun; 2022 Nov; 13(1):6548. PubMed ID: 36319643 [TBL] [Abstract][Full Text] [Related]
15. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Taube JH; Herschkowitz JI; Komurov K; Zhou AY; Gupta S; Yang J; Hartwell K; Onder TT; Gupta PB; Evans KW; Hollier BG; Ram PT; Lander ES; Rosen JM; Weinberg RA; Mani SA Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15449-54. PubMed ID: 20713713 [TBL] [Abstract][Full Text] [Related]
17. Expression of epithelial-mesenchymal transition biomarkers: Discoidin domain receptor 2, Snail-1, and Ovol-2 as predictors of clinical outcome in patients with epithelial ovarian carcinoma. Harb OA; Elfeky MA; El-Beshbishi W; Obaya AA; Abdallah WM; Ibrahim A; Awd AA; Embaby A J Cancer Res Ther; 2022; 18(4):1073-1082. PubMed ID: 36149163 [TBL] [Abstract][Full Text] [Related]
18. Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer. Liu Y; Fang Y; Bao L; Wu F; Wang S; Hao S Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291687 [TBL] [Abstract][Full Text] [Related]
19. STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation. Qiu Z; Dong B; Guo W; Piotr R; Longmore G; Yang X; Yu Z; Deng J; Evers BM; Wu Y Theranostics; 2021; 11(16):7658-7670. PubMed ID: 34335956 [TBL] [Abstract][Full Text] [Related]